Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Protara Therapeutics (TARA) Income towards Parent Company: 2013-2014

Historic Income towards Parent Company for Protara Therapeutics (TARA) over the last 2 years, with Dec 2014 value amounting to -$9.3 million.

  • Protara Therapeutics' Income towards Parent Company was N/A to -$3.3 million in Q4 2014 from the same period last year, while for Dec 2014 it was -$8.4 million, marking a year-over-year change of. This contributed to the annual value of -$9.3 million for FY2014, which is 16.48% down from last year.
  • As of FY2014, Protara Therapeutics' Income towards Parent Company stood at -$9.3 million, which was down 16.48% from -$8.0 million recorded in FY2013.
  • In the past 5 years, Protara Therapeutics' Income towards Parent Company ranged from a high of -$8.0 million in FY2013 and a low of -$9.3 million during FY2014.
  • Moreover, its 2-year median value for Income towards Parent Company was -$8.6 million (2013), whereas its average is -$8.6 million.
  • Data for Protara Therapeutics' Income towards Parent Company shows a maximum YoY declined of 16.48% (in 2014) over the last 5 years.
  • Yearly analysis of 2 years shows Protara Therapeutics' Income towards Parent Company stood at -$8.0 million in 2013, then fell by 16.48% to -$9.3 million in 2014.